Literature DB >> 16357136

Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.

Chongjuan Wei1, Christopher I Amos, L Clifton Stephens, Imelda Campos, Jian Min Deng, Richard R Behringer, Asif Rashid, Marsha L Frazier.   

Abstract

Peutz-Jeghers syndrome (PJS) is a dominantly inherited disorder characterized by gastrointestinal hamartomatous polyps and mucocutaneous melanin pigmentation. Germ line mutations in LKB1 cause PJS. We have generated mice carrying an Lkb1 exon 2 to 8 deletion by gene targeting in embryonic stem cells. Heterozygotes develop gastric hamartomas that are histologically similar to those found in humans with PJS. LKB1 is also reportedly a mediator of p53-dependent apoptosis. To explore the potential combined effects of p53 and Lkb1 alterations on tumorigenesis, we carried out a series of matings with Lkb1(+/-) and p53 null mice to generate Lkb1(+/-)/p53(+/-) and Lkb1(+/-)/p53(-/-) mice. Similar to the Lkb1(+/-) mice, gastrointestinal hamartomas have also been detected in the mice with these two genotypes. The Lkb1(+/-)/p53(+/-) mice displayed a dramatically reduced life span and increased tumor incidence compared to the mice with either Lkb1 or p53 single gene knockout. The time to onset of polyposis in Lkb1(+/-)/p53(-/-) mice is approximately 2 months earlier than Lkb1(+/-)/p53(+/-) and Lkb1(+/-) mice, whereas the latter two show a similar time to onset which is at approximately 6 months of age. These results strongly suggested that mutations of p53 and Lkb1 gene cooperate in the acceleration of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357136     DOI: 10.1158/0008-5472.CAN-05-0716

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Novel and recurrent mutations of STK11 gene in six Chinese cases with Peutz-Jeghers syndrome.

Authors:  Limeng Dai; Liyuan Fu; Dan Liu; Kun Zhang; Yuanyuan Wu; Hui Meng; Bo Zhang; Xingying Guan; Hong Guo; Yun Bai
Journal:  Dig Dis Sci       Date:  2014-03-07       Impact factor: 3.199

2.  Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

Authors:  Emmet J Jordan; Hyunjae R Kim; Maria E Arcila; David Barron; Debyani Chakravarty; JianJiong Gao; Matthew T Chang; Andy Ni; Ritika Kundra; Philip Jonsson; Gowtham Jayakumaran; Sizhi Paul Gao; Hannah C Johnsen; Aphrothiti J Hanrahan; Ahmet Zehir; Natasha Rekhtman; Michelle S Ginsberg; Bob T Li; Helena A Yu; Paul K Paik; Alexander Drilon; Matthew D Hellmann; Dalicia N Reales; Ryma Benayed; Valerie W Rusch; Mark G Kris; Jamie E Chaft; José Baselga; Barry S Taylor; Nikolaus Schultz; Charles M Rudin; David M Hyman; Michael F Berger; David B Solit; Marc Ladanyi; Gregory J Riely
Journal:  Cancer Discov       Date:  2017-03-23       Impact factor: 39.397

Review 3.  Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.

Authors:  Jennifer L Herrmann; Yevgeniya Byekova; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2011-03-29       Impact factor: 8.679

4.  Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report.

Authors:  Leonie Frauenfeld; Irina Bonzheim; Stefan Wirths; Julia Steinhilber; Marius Horger; Barbara Mankel; Wolfgang Bethge; Falko Fend; Birgit Federmann
Journal:  Virchows Arch       Date:  2019-07-17       Impact factor: 4.064

Review 5.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

6.  CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.

Authors:  Hernan Roca; Zachary S Varsos; Kenneth J Pienta
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.

Authors:  Chongjuan Wei; Christopher I Amos; Nianxiang Zhang; Jing Zhu; Xiaopei Wang; Marsha L Frazier
Journal:  Cancer Lett       Date:  2009-01-14       Impact factor: 8.679

8.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

9.  LKB1 deficiency promotes proliferation and invasion of glioblastoma through activation of mTOR and focal adhesion kinase signaling pathways.

Authors:  Keqiang Zhang; Jinghan Wang; Jinhui Wang; Frank Luh; Xiyong Liu; Lu Yang; Yun-Ru Liu; Leila Su; Yu-Chen Sh Yang; Peiguo Chu; Yun Yen
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

10.  A 23-Nucleotide Deletion in STK11 Gene Causes Peutz-Jeghers Syndrome and Malignancy in a Chinese Patient Without a Positive Family History.

Authors:  Zi-Ye Zhao; Yu-Liang Jiang; Bai-Rong Li; Fu Yang; Jing Li; Xiao-Wei Jin; Shou-Bin Ning; Shu-Han Sun
Journal:  Dig Dis Sci       Date:  2017-10-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.